Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-15 Sale | 2023-08-17 4:40 pm | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Innovation Officer | 2,740 | $169 | $463,052 | 81,633 (Direct) | View |
| 2023-05-15 Sale | 2023-05-17 4:34 pm | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Innovation Officer | 6,233 | $84.56 | $527,063 | 78,373 (Direct) | View |
| 2023-03-07 Sale | 2023-03-08 5:04 pm | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Innovation Officer | 621 | $84.57 | $52,518 | 84,606 (Direct) | View |
| 2023-03-02 Sale | 2023-03-06 5:04 pm | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Innovation Officer | 93,922 | $86.72 | $8,145,224 | 322,471 (Direct) | View |
| 2021-06-14 Sale | 2021-06-16 4:04 pm | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer | 60,000 | $142.58 | $8,554,906 | 532,419 (Direct) | View |
| 2020-11-16 Sale | 2020-11-18 4:19 pm | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer | 25,000 | $169.57 | $4,239,148 | 519,783 (Direct) | View |
| 2020-11-09 Sale | 2020-11-10 5:59 pm | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer | 25,000 | $175 | $4,375,000 | 72,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-09-26 Disposition | 2023-09-26 4:30 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Innovation Officer | 649,112 | $0 | 0 (Direct) | View |
| 2023-07-06 Option Award | 2023-07-10 4:45 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Innovation Officer | 6,000 | $0 | 84,373 (Direct) | View |
| 2023-03-02 Conversion | 2023-03-06 5:04 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Innovation Officer | 88,636 | $0 | 322,471 (Direct) | View |
| 2023-03-02 Exercise | 2023-03-06 5:04 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Innovation Officer | 88,636 | $11 | 322,471 (Direct) | View |
| 2023-03-02 Exercise | 2023-03-06 5:04 pm | N/A 2026-05-25 | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Innovation Officer | 88,636 | $0 | 322,471 (Direct) | View |
| 2023-02-28 Option Award | 2023-03-01 4:18 pm | N/A 2032-01-03 | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Innovation Officer | 45,000 | $0 | 120,513 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 5:01 pm | N/A 2033-01-03 | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Innovation Officer | 118,988 | $0 | 170,988 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 4:08 pm | N/A 2032-01-03 | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer | 105,000 | $0 | 122,000 (Direct) | View |
| 2021-06-14 Conversion | 2021-06-16 4:04 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer | 5,000 | $0 | 532,419 (Direct) | View |
| 2021-06-16 Exercise | 2021-06-16 4:04 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer | 19,525 | $11.62 | 532,419 (Direct) | View |
| 2021-06-16 Exercise | 2021-06-16 4:04 pm | N/A 2023-06-15 | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer | 19,525 | $0 | 532,419 (Direct) | View |
| 2021-01-04 Option Award | 2021-01-06 4:40 pm | N/A 2031-01-04 | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer | 24,000 | $0 | 24,000 (Direct) | View |
| 2020-11-16 Conversion | 2020-11-18 4:19 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer | 25,000 | $0 | 519,783 (Direct) | View |
| 2020-11-16 Exercise | 2020-11-18 4:19 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer | 25,000 | $11 | 519,783 (Direct) | View |
| 2020-11-16 Exercise | 2020-11-18 4:19 pm | N/A 2026-05-25 | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Research Officer | 25,000 | $0 | 519,783 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-06 3:00 pm | N/A 2030-01-02 | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Medical Officer | 25,000 | $0 | 25,000 (Direct) | View |
| 2019-12-16 Conversion | 2019-12-17 5:21 pm | N/A N/A | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Medical Officer | 69,828 | $0 | 156,779 (Direct) | View |
| 2019-10-14 Option Award | 2019-11-12 5:35 pm | N/A 2029-01-02 | REATA PHARMACEUTICALS INC | RETA | Meyer Colin John Chief Medical Officer | 35,500 | $0 | 35,500 (Direct) | View |